Golden Biotechnology Corp. ( TW 4132) has won the 13th National Innovation Award in Enterprise Innovation category in Taiwan with its ” Hocena, an update on its clinical status as anti-cancer and anti-hyperlipidemia novel drug”. The novel small molecule was extracted from Taiwanese Antrodia camphorata with new mechanism of action and is capable of inhibiting RAS related mutation tumor. Golden Biotechnology Corp. has also equipped with unique and complete production line and undergoing the development of chemical synthesis of the new drug.